November 2, 2016

Gene Mutations May Increase Adverse Event Risk in Older Adults Taking Multiple Meds

Gene mutations that affect drug metabolism may explain higher hospitalization rates for some older adults taking multiple medications, according to researchers from Columbia University.
October 13, 2016

A Jack of All Trades: An Interview with Kam Leong

Kam Leong, a versatile biomedical engineer originally trained in chemical engineering, has developed an impressive array of innovative nanotechnologies that have opened up new opportunities in biomedical research and drug delivery.
October 13, 2016

Mathematical Model Sheds Light on How the Brain Makes New Memories While Preserving the Old

A new mathematical model created by Columbia illustrates how the brain maintains the fidelity of memories for years, decades or even a lifetime.
October 10, 2016

Dangerous Drug Interactions Uncovered with Data Science

Researchers at Columbia University Medical Center and the Data Science Institute at Columbia University have uncovered a potentially dangerous drug interaction using data science.
September 26, 2016

Bringing High-Performance Materials into Sharper Focus

Nanoscientists have a new tool that promises to put long-lasting batteries and super-efficient solar panels within closer reach. Atomic Electron Tomography lets scientists precisely map the coordinates of individual atoms within a nanoparticle, or tiny cluster of a few hundred atoms.
September 22, 2016

Columbia Chemists Find Key to Manufacturing More Efficient Solar Cells

Columbia scientists have demonstrated it is possible to manufacture solar cells that are far more efficient than existing silicon energy cells by using a new kind of material, a development that could help reduce fossil fuel consumption.
July 8, 2016

Four NYC Medical Centers Receive New NIH Precision Medicine Grant

Columbia University Medical Center and Weill Cornell Medicine, in collaboration with NewYork-Presbyterian and NYC Health + Hospitals/Harlem, have been awarded a grant from the NIH for approximately $4 million to enroll participants in the Cohort Program of President Barack Obama’s Precision Medicine Initiative.